We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Protagen, Inova Announce Agreement for BICD2 Biomarker

News   Aug 12, 2016

 
Protagen, Inova Announce Agreement for BICD2 Biomarker
 
 
Advertisement
 

RELATED ARTICLES

Microbiome-based Diagnostic Tool Can Detect Liver Fibrosis and Cirrhosis in Stool Samples

News

A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

READ MORE

Novel Pathology Could Improve Diagnosis and Treatment of Huntington’s Disease

News

Researchers have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease, and could be used to improve their diagnosis and treatment.

READ MORE

Next-generation Sequencing To Provide Precision Medicine for Rare Metabolic Disorders

News

Scientists have uncovered the genetic basis of aromatase deficiency – a rare metabolic disorder – using next-generation sequencing, paving the way towards precision medicine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE